TY - JOUR
T1 - Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections
AU - Dubey, Ankit Kumar
AU - Chaudhry, Suman Kumar
AU - Singh, Harikesh Bahadur
AU - Gupta, Vijai Kumar
AU - Kaushik, Ajeet
PY - 2022/3
Y1 - 2022/3
N2 - Optimized therapeutic bio-compounds supported by bio-acceptable nanosystems (i.e., precise nanomedicine) have ability to promote health via maintaining body structure, organ function, and controlling chronic and acute effects. Therefore, nano-nutraceuticals (designed to neutralize virus, inhibit virus bindings with receptors, and support immunity) utilization can manage COVID-19 pre/post-infection effects. To explore these approaches well, our mini-review explores optimized bio-active compounds, their ability to influence SARS-CoV-2 infection, improvement in performance supported by precise nanomedicine approach, and challenges along with prospects. Such optimized pharmacologically relevant therapeutic cargo not only affect SARS-CoV-2 but will support other organs which show functional alternation due to SARS-CoV-2 for example, neurological functions. Hence, coupling the nutraceuticals with the nano-pharmacology perspective of higher efficacy via targeted delivery action can pave a novel way for health experts to plan future research needed to manage post COVID-19 infection effect where a longer efficacy with no side-effects is a key requirement.
AB - Optimized therapeutic bio-compounds supported by bio-acceptable nanosystems (i.e., precise nanomedicine) have ability to promote health via maintaining body structure, organ function, and controlling chronic and acute effects. Therefore, nano-nutraceuticals (designed to neutralize virus, inhibit virus bindings with receptors, and support immunity) utilization can manage COVID-19 pre/post-infection effects. To explore these approaches well, our mini-review explores optimized bio-active compounds, their ability to influence SARS-CoV-2 infection, improvement in performance supported by precise nanomedicine approach, and challenges along with prospects. Such optimized pharmacologically relevant therapeutic cargo not only affect SARS-CoV-2 but will support other organs which show functional alternation due to SARS-CoV-2 for example, neurological functions. Hence, coupling the nutraceuticals with the nano-pharmacology perspective of higher efficacy via targeted delivery action can pave a novel way for health experts to plan future research needed to manage post COVID-19 infection effect where a longer efficacy with no side-effects is a key requirement.
KW - COVID-19 infection
KW - Immunity
KW - Nanoparticles
KW - Nutraceuticals
KW - Phytochemicals
KW - SARS-CoV-2
KW - Therapeutics
UR - http://www.scopus.com/inward/record.url?scp=85124549868&partnerID=8YFLogxK
U2 - 10.1016/j.btre.2022.e00712
DO - 10.1016/j.btre.2022.e00712
M3 - Review article
C2 - 35186674
AN - SCOPUS:85124549868
SN - 2215-017X
VL - 33
JO - Biotechnology Reports
JF - Biotechnology Reports
M1 - e00712
ER -